Bafilomycin A1 targets patient-derived CD34⁺CD19⁺ leukemia stem cells

Affiliations

• ¹ Hematology Center of Cyrus Tang Medical Institute, Jiangsu Institute of Hematology, Collaborative Innovation Center of Hematology, Soochow University School of Medicine, Suzhou.
• ² Hematology Center of Cyrus Tang Medical Institute, Jiangsu Institute of Hematology, Collaborative Innovation Center of Hematology, Soochow University School of Medicine, Suzhou nyuan@suda.edu.cn.
• ³ Department of Hematology, Institute of Blood and Marrow Transplantation, Jiangsu Institute of Hematology, First Affiliated Hospital of Soochow University, Suzhou.
• ⁴ Department of Hematology, Institute of Blood and Marrow Transplantation, Jiangsu Institute of Hematology, First Affiliated Hospital of Soochow University, Suzhou wudepei@suda.edu.cn.
• ⁵ Hematology Center of Cyrus Tang Medical Institute, Jiangsu Institute of Hematology, Collaborative Innovation Center of Hematology, Soochow University School of Medicine, Suzhou jrwang@suda.edu.cn.
• ⁶ Key Laboratory of Stem Cells and Biomedical Materials of Jiangsu Province and Chinese Ministry of Science and Technology, State Key Laboratory of Radiation Medicine and Radioprotection, Soochow University, Suzhou, China.